Biosimilar Interchangeability Designation Would Be Nixed Under Biden Proposal

 
• By Derrick Gingery
  
budget
The FDA would receive about $7.2bn in budget authority and user fees in Biden's FY 2025 budget request. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics